The North America alfentanil market is expected to maintain its leading position through 2034, supported by advanced healthcare infrastructure, high surgical procedure volumes, and the widespread adoption of sophisticated anesthesia practices. North America accounted for approximately 39–43% of the global alfentanil market in 2025 and is projected to expand at a CAGR of 5.2%–5.7%...